Kanarb likely to be prescribed in 40 general hospitals in second half

Published: 2011-05-20 06:59:00
Updated: 2011-05-20 06:59:00
Boryung Pharmaceutical is enjoying brisk sales of its new antihypertensive drug, Kanarb (fimasartan).

Monthly sales of Kanarb is expected to reach 1,000 million won in the first half of this year, as it has succeeded to land in 40 general hospitals and 6,800 clinics nationwide since its releas...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.